EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C41H64O14 |
| Net Charge | 0 |
| Average Mass | 780.949 |
| Monoisotopic Mass | 780.42961 |
| SMILES | [H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@@H](C5=CC(=O)OC5)CC[C@@]43O)[C@@]1(C)CC[C@H](O[C@H]1C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4C[C@H](O)[C@H](O)[C@@H](C)O4)[C@@H](C)O3)[C@@H](C)O1)C2 |
| InChI | InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19-,20-,21-,23-,24+,25-,26-,27+,28+,29+,30+,31-,33+,34+,35+,36-,37-,38-,39+,40+,41+/m1/s1 |
| InChIKey | LTMHDMANZUZIPE-PUGKRICDSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | epitope The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds. EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor An EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that interferes with the action of Na+/K+-transporting ATPase (EC 3.6.3.9). metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Applications: | anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. cardiotonic drug A drug that has a strengthening effect on the heart or that can increase cardiac output. cardioprotective agent Any protective agent that is able to prevent damage to the heart. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| digoxin (CHEBI:4551) has role anti-arrhythmia drug (CHEBI:38070) |
| digoxin (CHEBI:4551) has role cardiotonic drug (CHEBI:38147) |
| digoxin (CHEBI:4551) has role EC 3.6.3.9 (Na+/K+-transporting ATPase) inhibitor (CHEBI:63510) |
| digoxin (CHEBI:4551) has role epitope (CHEBI:53000) |
| digoxin (CHEBI:4551) is a cardenolide glycoside (CHEBI:38092) |
| digoxin (CHEBI:4551) is a steroid saponin (CHEBI:61655) |
| digoxin (CHEBI:4551) is conjugate acid of digoxin(1−) (CHEBI:145795) |
| Incoming Relation(s) |
| 12-O-acetyldigoxin (CHEBI:71006) has functional parent digoxin (CHEBI:4551) |
| 20,22-dihydrodigoxin (CHEBI:71002) has functional parent digoxin (CHEBI:4551) |
| digoxin(1−) (CHEBI:145795) is conjugate base of digoxin (CHEBI:4551) |
| IUPAC Name |
|---|
| (3β,5β,12β)-3-{[2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide |
| INN | Source |
|---|---|
| digoxin | ChemIDplus |
| Synonym | Source |
|---|---|
| 12β-hydroxydigitoxin | ChemIDplus |
| Citations |
|---|